Evaluation of the efficacy of the anti-ulcer oral mucosal protective agent RADoralex® in the prevention and treatment of radiation-induced oral mucosal reactions induced during treatment of nasopharyngeal carcinoma

The aim of this study was to evaluate the efficacy and safety of antiulcer oral mucosal protectant-RADoralex® in the prevention and treatment of radiation-induced oral mucosal reactions elicited during intensity-modulated radiation therapy (IMRT). for locally advanced nasopharyngeal carcinoma (NPC)....

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Jun, Xie, Jirui, Lin, Jiawei, Weng, Chengyin, Lu, Shun, Xu, Peng, Zhang, Shuo, Luo, Cheng, Huang, Yecai, Li, Lu, Lang, Jinyi, Feng, Mei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812764/
https://www.ncbi.nlm.nih.gov/pubmed/34989325
http://dx.doi.org/10.1080/15384047.2021.2013704

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812764/
https://www.ncbi.nlm.nih.gov/pubmed/34989325
http://dx.doi.org/10.1080/15384047.2021.2013704

Ejemplares similares